EU has deal with Moderna for supply of COVID-19 vaccine candidate

By: |
Updated: Nov 24, 2020 6:24 PM

Last week Moderna said its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial.

The deal will be formally approved by the EU executive on Wednesday, Ursula von der Leyen said."I am happy to announce that tomorrow we will approve a new contract to secure another COVID-19 vaccine," Ursula von der Leyen said, adding the deal "allows us to buy up to 160 million doses of a vaccine produced by Moderna."

The European Union has reached a deal with U.S. biotech firm Moderna for the supply of its COVID-19 vaccine candidate, the head of the European Commission said on Tuesday.

Last week Moderna said its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial.

“I am happy to announce that tomorrow we will approve a new contract to secure another COVID-19 vaccine,” Ursula von der Leyen said, adding the deal “allows us to buy up to 160 million doses of a vaccine produced by Moderna.”

In August the EU’s executive Commission, which co-leads talks with vaccine makers on behalf of member states, said preliminary talks with Moderna had been concluded with the aim of signing a contract for the supply of 80 million doses of its vaccine, with the option of buying another 80 million.

It is the sixth supply deal the EU has negotiated with vaccine makers to secure COVID-19 shots.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Amitabh Bachchan hails COVID-19 vaccination drive, hopes to eradicate coronavirus like polio from India
2Covid-19 vaccination: Maharashtra reports 10 cases of mild adverse effect post jab; some suffer minor reactions in other states
3India records 15,144 fresh COVID-19 cases